Menu

Amgen’s Imdelltra Combination Reduced the Risk of Death by 58% in a Phase 3 Trial for Small-Cell Lung Cancer

#stocks#redditstocks#amgen#imfinzi#results
Reading 0:00
15s threshold

Amgen ($AMGN) announced Phase 3 trial results showing that combining Imdelltra with Imfinzi reduced the risk of death by 58% in patients with small-cell lung cancer, compared with Imfinzi alone.…

Anonymous readers can preview up to 1024 characters here. Log in to unlock the full article once ingest succeeds.